Leading the Way in Life Science Technologies

GEN Exclusives

More »
Readers Comments Back to Item »

The Global Outlook for Regenerative Medicine and Stem Cells

1 Readers' Comments

Posted by: Editor: http//stemcelldigest.net

08/25/2009

The stem cell sector we cover, consisting of twenty companies all traded on U.S. exchanges, has shown the ability to raise capital even in the difficult environment of the last twelve months. I agree about the patent issue and the confusion that abounds there. Legal and regulatory harmonization is probably a long way off and will follow rather than lead the development of applicable therapies.

  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »